03.03.2015 08:15:34
|
DSM publishes 2014 Integrated Annual Report
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the publication of its 2014 Integrated Annual Report.
DSM's Integrated Annual Report is based on the guidelines of the Global Reporting Initiative and further developed in 2014 with the implementation of G4, the fourth generation of sustainability reporting guidelines.
The 2014 Integrated Annual Report can be downloaded from DSM's website, www.dsm.com and via the DSM IR app. An interactive version is also available on the website.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM has around 21,000 employees and delivers annual net sales of more than €9 billion. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
For more information:
DSM Corporate Communications Herman Betten tel. +31 (0) 45 5782017 e-mail media.contacts@dsm.com | DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 e-mail investor.relations@dsm.com |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DSM NVmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu DSM NVmehr Analysen
Aktien in diesem Artikel
DSM NV | 108,95 | -0,86% |